Edition:
United States

Intec Pharma Ltd (NTEC.OQ)

NTEC.OQ on NASDAQ Stock Exchange Capital Market

4.95USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$4.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,484
52-wk High
$9.80
52-wk Low
$4.20

Chart for

About

Intec Pharma Ltd is an Israel-based drug development company. It is a development stage biopharmaceutical company that develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill, a novel gastro-retentive delivery system, improves the pharmacokinetics and pharmacodyna... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 198.20 16.04
EPS (TTM): -- -- --
ROI: -- -11.76 34.69
ROE: -- -36.72 15.46

BRIEF-Intec Pharma reports Q3 earnings per share $0.40

* Intec Pharma reports third quarter 2017 operating and financial results

Nov 15 2017

BRIEF-Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma

* Acuta Capital Partners reports 10.5 pct passive stake in Intec Pharma Ltd as of Aug 31 - SEC filing Source text: (http://bit.ly/2gRgBs0) Further company coverage:

Sep 08 2017

BRIEF-Adage Capital Partners reports 6.64 pct passive stake in Intec Pharma

* Adage Capital Partners GP LLC reports 6.64 percent passive stake in Intec Pharma Ltd ‍​as of August 16 - sec filing Source text : http://bit.ly/2vvPmop Further company coverage:

Aug 25 2017

BRIEF-Intec Pharma announces pricing of $50 mln public offering of ordinary shares

* Intec Pharma announces pricing of $50.0 million public offering of ordinary shares

Aug 16 2017

BRIEF-Intec Pharma announces proposed public offering of ordinary shares

* Intec Pharma announces proposed public offering of ordinary shares

Aug 15 2017

BRIEF-Intec Pharma reports financial results for the first half of 2017​

* Intec Pharma reports financial results for the first six months of 2017

Aug 09 2017

BRIEF-Intec Pharma reports clinical results from phase I trial of accordion pill for cannabinoid therapies

* Intec Pharma reports clinical results from phase i trial of accordion pill for cannabinoid therapies

Aug 03 2017

BRIEF-Intec Pharma granted patent in Hong Kong for Accordion pill

* Intec Pharma Ltd says granted patent in Hong Kong for Accordion pill

Jul 19 2017

BRIEF-Intec Pharma Ltd appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as CEO

* Intec Pharma Ltd - Intec Pharma appoints U.S. Life sciences executive and vice chairman Jeffrey Meckler as chief executive officer‍​

Jul 10 2017

BRIEF-Intec Pharma appoints Jeffrey Meckler as CEO

* Intec Pharma appoints U.S. Life Sciences executive and vice chairman Jeffrey A. Meckler as chief executive officer

Jul 10 2017

Earnings vs. Estimates